Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Income from Continuing Operations (2024 - 2025)

Kura Oncology (KURA) has disclosed Income from Continuing Operations for 2 consecutive years, with 80999000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 370.95% to 80999000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 278666000.0 through Dec 2025, down 62.05% year-over-year, with the annual reading at 278666000.0 for FY2025, 60.17% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 80999000.0 at Kura Oncology, down from 74116000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 17199000.0 in Q4 2024, with the low at 80999000.0 in Q4 2025.